CF33-hNIS-antiPDL1 shows efficacy in models of gastric cancer peritoneal carcinomatosis
Jan. 25, 2023
Genetically modified derivatives of the chimeric oncolytic virus (OV) CF33 have previously shown cancer selectivity and oncolytic potency against various solid tumors.
